{"transactions":[{"id":1068949,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":274990,"ownership":{"direct":false,"nature":"By Versant Vantage II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage II, L.P. (\"Vantage II\"). Versant Vantage II GP, L.P. (\"Vantage II GP\") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (\"Vantage II GP-GP\") is the sole general partner of Vantage II GP. Dr. Davis, a member of the Issuer's board of directors, is a managing director of Vantage II GP-GP. Each of Vantage II GP-GP, Vantage II GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Vantage II, and each disclaims beneficial ownership of the shares held by Canada V, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1068948,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":82006,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Dr. Davis, a member of the Issuer's board of directors, is a managing director of Versant V GP. Each of Versant V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Affiliates V, and each disclaims beneficial ownership of the shares held by Affiliates, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1068947,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":90888,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Dr. Davis, a member of the Issuer's board of directors, is a managing director of Versant V GP. Each of Versant V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Ophthalmic, and each disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1068946,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":207486,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Dr. Davis, a member of the Issuer's board of directors, is a director of Canada V GP-GP. Each of Canada V GP-GP, Canada V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Canada V, and each disclaims beneficial ownership of the shares held by Canada V, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1068945,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T16:34:57.000Z","date":"2025-08-08","kind":"other","planned":false,"acquired":false,"shares":2726322,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated June 26, 2025, by and among the Issuer, XOMA Royalty Corporation (\"Purchaser\") and XRA 3 Corp., a wholly-owned subsidiary of Purchaser, pursuant to which Purchaser completed a cash tender offer (the \"Offer\")for all outstanding shares of common stock of the Issuer for (i) $0.34 per share in cash, payable subject to any applicable tax withholding and without interest, plus (ii) one non-transferable contractual contingent value right per share, payable subject to any applicable tax withholding and without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis (\"Dr. Davis\"), a member of the Issuer's board of directors, is a managing director of Versant V GP. Each of Versant V GP and Dr. Davis may be deemed to share voting and dispositive power over the shares held by Versant V, and each disclaims beneficial ownership of the shares held by Versant V, except to the extent of their respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-107403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000095017025107403/ownership.xml","form_type":"4"}},{"id":1822198,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":2196402,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Vantage II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage II, L.P. (\"Vantage II\"). Versant Vantage II GP, L.P. (\"Vantage II GP\") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (Vantage II GP-GP\") is the sole general partner of Vantage II GP. Jerel C. Davis is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":274990},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822197,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":33682,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4216},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822196,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":37283,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4667},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822195,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":85217,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10669},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822194,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":1119729,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":140190},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822193,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":230117,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28810},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822192,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":255081,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":31936},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822191,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":582206,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":72892},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822190,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":7650043,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":957787},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822189,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":106208,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13297},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822188,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":117730,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14739},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822187,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":268711,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33642},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822186,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":3530789,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":442055},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822185,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":237575,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29744},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822184,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":263349,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":32971},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822183,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":601077,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":75255},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822182,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":false,"shares":7897999,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":988832},"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822181,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":5939,"price":12,"value":71268.0,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":82006,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822180,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":6575,"price":12,"value":78900.0,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":90888,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822179,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":15028,"price":12,"value":180336.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":207486,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822178,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":197458,"price":12,"value":2369496.0,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":2726322,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822177,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":274990,"ownership":{"direct":false,"nature":"By Versant Vantage II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage II, L.P. (\"Vantage II\"). Versant Vantage II GP, L.P. (\"Vantage II GP\") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (Vantage II GP-GP\") is the sole general partner of Vantage II GP. Jerel C. Davis is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":274990,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822176,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":76067,"ownership":{"direct":false,"nature":"By Versant Affiliates Fund V, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Versant Affiliates Fund V, L.P. (\"Affiliates V\"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":76067,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822175,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":84313,"ownership":{"direct":false,"nature":"By Versant Ophthalmic Affiliates Fund I, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. (\"Ophthalmic\"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":84313,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822174,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":192458,"ownership":{"direct":false,"nature":"By Versant Venture Capital V (Canada) LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Versant Venture Capital V (Canada) LP (\"Canada V\"). Versant Ventures V (Canada), L.P. (\"Canada V GP\") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. (\"Canada V GP-GP\") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":192458,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":1822173,"issuer":{"id":76646,"kind":"organization","name":"Turnstone Biologics Corp.","symbol":"TSBX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":2,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":3,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":6,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":8,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":9,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":10,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-27T16:23:01.000Z","date":"2023-07-25","kind":"exercise","planned":false,"acquired":true,"shares":2528864,"ownership":{"direct":false,"nature":"By Versant Venture Capital V, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Versant Venture Capital V, L.P. (\"Versant V\"). Versant Ventures V, LLC (\"Versant V GP\") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports."}],"balance_after":2528864,"source":{"system":"sec-edgar","filing":"0001209191-23-043527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919123043527/doc4.xml","form_type":"4"}},{"id":2240331,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":10099,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F18","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F17","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240330,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":true,"shares":10099,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F17","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":10099,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240329,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":46753,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F15","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V (Canada) to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Venture Capital V (Canada) LP (\"VVC V (Canada)\"). Versant Ventures V (Canada) GP-GP, Inc. (\"VV V (Canada) GP\") is the sole general partner of Versant Ventures V (Canada), L.P. (\"VV V (Canada)\") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":64731,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240328,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":141103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V, to its members."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240327,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":true,"shares":4419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VOAF I."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":141103,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240326,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":20454,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VOAF I to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Versant Ophthalmic Affiliates Fund I, L.P. (\"VOAF I\"). VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":28322,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240325,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":true,"shares":3992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VAF V."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":136684,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240324,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":18478,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VAF V to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Affiliates Fund V, L.P. (\"VAF V\"). VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":25587,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240323,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":true,"shares":132692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":132692,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240322,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-06","kind":"other","acquired":false,"shares":614315,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Venture Capital V, L.P. (\"VVC V\"). Versant Ventures V, LLC (\"VV V\") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":850560,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240321,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":33395,"price":12.2517,"value":409145.5215,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Venture Capital V (Canada) LP (\"VVC V (Canada)\"). Versant Ventures V (Canada) GP-GP, Inc. (\"VV V (Canada) GP\") is the sole general partner of Versant Ventures V (Canada), L.P. (\"VV V (Canada)\") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":111484,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240320,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":14611,"price":12.2517,"value":179009.5887,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Versant Ophthalmic Affiliates Fund I, L.P. (\"VOAF I\"). VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":48776,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240319,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":13199,"price":12.2517,"value":161710.1883,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Affiliates Fund V, L.P. (\"VAF V\"). VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":44065,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240318,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":438795,"price":12.2517,"value":5375984.7015,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant Venture Capital V, L.P. (\"VVC V\"). Versant Ventures V, LLC (\"VV V\") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":1464875,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2240317,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-07T20:36:15.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":250000,"price":12.2517,"value":3062925.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2344451,"source":{"system":"sec-edgar","filing":"0000899243-22-021348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924322021348/doc4.xml","form_type":"4"}},{"id":2610187,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:44:12.000Z","date":"2021-08-05","kind":"other","acquired":false,"shares":2260,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-032177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032177/doc4.xml","form_type":"4"}},{"id":2610186,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:44:12.000Z","date":"2021-08-05","kind":"other","acquired":true,"shares":2260,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of VV I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2260,"source":{"system":"sec-edgar","filing":"0000899243-21-032177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032177/doc4.xml","form_type":"4"}},{"id":2610185,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:44:12.000Z","date":"2021-08-05","kind":"other","acquired":false,"shares":2279,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-032177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032177/doc4.xml","form_type":"4"}},{"id":2610184,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:44:12.000Z","date":"2021-08-05","kind":"other","acquired":true,"shares":2279,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of VV I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2279,"source":{"system":"sec-edgar","filing":"0000899243-21-032177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032177/doc4.xml","form_type":"4"}},{"id":2610183,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-08-09T20:44:12.000Z","date":"2021-08-05","kind":"other","acquired":false,"shares":152071,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. (\"VV I\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by VV I. Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":231211,"source":{"system":"sec-edgar","filing":"0000899243-21-032177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321032177/doc4.xml","form_type":"4"}},{"id":2683580,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:31:20.000Z","date":"2021-06-01","kind":"other","acquired":false,"shares":1119,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-021798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021798/doc4.xml","form_type":"4"}},{"id":2683579,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:31:20.000Z","date":"2021-06-01","kind":"other","acquired":true,"shares":1119,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of VV I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":1119,"source":{"system":"sec-edgar","filing":"0000899243-21-021798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021798/doc4.xml","form_type":"4"}},{"id":2683578,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:31:20.000Z","date":"2021-06-01","kind":"other","acquired":false,"shares":1128,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-021798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021798/doc4.xml","form_type":"4"}},{"id":2683577,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:31:20.000Z","date":"2021-06-01","kind":"other","acquired":true,"shares":1128,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of VV I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":1128,"source":{"system":"sec-edgar","filing":"0000899243-21-021798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021798/doc4.xml","form_type":"4"}},{"id":2683576,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-03T20:31:20.000Z","date":"2021-06-01","kind":"other","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. (\"VV I\"), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by VV I. Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":383282,"source":{"system":"sec-edgar","filing":"0000899243-21-021798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321021798/doc4.xml","form_type":"4"}},{"id":2723387,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":false,"shares":3473,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2723386,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":true,"shares":3473,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":3473,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2723385,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":false,"shares":16079,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V (Canada) LP (\"VVC V (Canada)\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Shares held by VVC V (Canada). Versant Ventures V (Canada) GP-GP, Inc. (\"VV V (Canada) GP\") is the sole general partner of Versant Ventures V (Canada), L.P. (\"VV V (Canada)\") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":144879,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2723384,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":false,"shares":48528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V, to its members."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2723383,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":true,"shares":1520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VOAF I."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":48528,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2723382,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":false,"shares":7035,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ophthalmic Affiliates Fund I, L.P. (\"VOAF I\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by VOAF I. VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":63387,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2723381,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":true,"shares":1373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VAF V."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":47008,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2723380,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":false,"shares":6355,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Affiliates Fund V, L.P. (\"VAF V\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by VAF V. VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":57264,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2723379,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":true,"shares":45635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":45635,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2723378,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-05-07T20:38:00.000Z","date":"2021-05-05","kind":"other","acquired":false,"shares":211277,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V, L.P. (\"VVC V\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by VVC V. Versant Ventures V, LLC (\"VV V\") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":1903670,"source":{"system":"sec-edgar","filing":"0000899243-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321018685/doc4.xml","form_type":"4"}},{"id":2850694,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":false,"shares":745,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2850693,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":true,"shares":745,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a change in the form of ownership of VV I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":745,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2850692,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2850691,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":true,"shares":751,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a change in the form of ownership of VV I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":751,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2850690,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. (\"VV I\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares held by VV I. Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":458282,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2850689,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":false,"shares":5176,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2850688,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":true,"shares":5176,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of VV VI GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by VV VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":5176,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2850687,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV VI. VV VI GP is the sole general partner of VV VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI. Each of VV VI GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2850686,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of VV VI by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by VV VI. VV VI GP is the sole general partner of VV VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI. Each of VV VI GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2850685,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-18T22:09:16.000Z","date":"2021-02-16","kind":"other","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. (\"VVC VI\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by VVC VI. Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2594451,"source":{"system":"sec-edgar","filing":"0000899243-21-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321007140/doc4.xml","form_type":"4"}},{"id":2886129,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":745,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F32","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F31","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886128,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":true,"shares":745,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F30","text":"Represents a change in the form of ownership of VV I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F31","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":745,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886127,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F29","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F28","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886126,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":true,"shares":751,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F27","text":"Represents a change in the form of ownership of VV I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F28","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":751,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886125,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F25","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. (\"VV I\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F26","text":"Shares held by VV I. Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"VV I GP\") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":508282,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886124,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":4313,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F24","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F23","text":"Shares held by VV VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886123,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":true,"shares":4313,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F22","text":"Represents a change in the form of ownership of VV VI GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F23","text":"Shares held by VV VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":4313,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886122,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F21","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F20","text":"Shares held by VV VI. VV VI GP is the sole general partner of VV VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI. Each of VV VI GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886121,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F19","text":"Represents a change in the form of ownership of VV VI by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F20","text":"Shares held by VV VI. VV VI GP is the sole general partner of VV VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI. Each of VV VI GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886120,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F17","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. (\"VVC VI\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F18","text":"Shares held by VVC VI. Versant Ventures VI GP-GP, LLC (\"VV VI GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"VV VI\") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2894451,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886119,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":4328,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886118,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":true,"shares":4328,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":4328,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886117,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":20037,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V (Canada) LP (\"VVC V (Canada)\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Shares held by VVC V (Canada). Versant Ventures V (Canada) GP-GP, Inc. (\"VV V (Canada) GP\") is the sole general partner of Versant Ventures V (Canada), L.P. (\"VV V (Canada)\") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":160958,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886116,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":60472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V, to its members."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886115,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":true,"shares":1893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VOAF I."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":60472,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886114,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":8766,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ophthalmic Affiliates Fund I, L.P. (\"VOAF I\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Shares held by VOAF I. VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":70422,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886113,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":true,"shares":1711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VAF V."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":58579,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886112,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":7919,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Affiliates Fund V, L.P. (\"VAF V\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by VAF V. VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":63619,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886111,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":true,"shares":56868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":56868,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2886110,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T23:54:22.000Z","date":"2021-01-29","kind":"other","acquired":false,"shares":263278,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V, L.P. (\"VVC V\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by VVC V. Versant Ventures V, LLC (\"VV V\") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2114947,"source":{"system":"sec-edgar","filing":"0000899243-21-004272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321004272/doc4.xml","form_type":"4"}},{"id":2904606,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-01-20T01:16:47.000Z","date":"2021-01-14","kind":"other","acquired":false,"shares":745,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F32","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F31","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-002407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321002407/doc4.xml","form_type":"4"}},{"id":2904605,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-01-20T01:16:47.000Z","date":"2021-01-14","kind":"other","acquired":true,"shares":745,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F30","text":"Represents a change in the form of ownership of VV I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F31","text":"Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":745,"source":{"system":"sec-edgar","filing":"0000899243-21-002407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321002407/doc4.xml","form_type":"4"}},{"id":2904604,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-01-20T01:16:47.000Z","date":"2021-01-14","kind":"other","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F29","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F28","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-002407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321002407/doc4.xml","form_type":"4"}},{"id":2904603,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":1,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":2,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":3,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":4,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76651,"kind":"organization","name":"Versant Ventures V GP-GP (Canada), Inc.","position":5,"cik":"0001619297","reported_name":"Versant Ventures V GP-GP (Canada), Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":6,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":7,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":8,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":9,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":10,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-01-20T01:16:47.000Z","date":"2021-01-14","kind":"other","acquired":true,"shares":751,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F27","text":"Represents a change in the form of ownership of VV I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F28","text":"Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":751,"source":{"system":"sec-edgar","filing":"0000899243-21-002407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000089924321002407/doc4.xml","form_type":"4"}}],"next_cursor":"2021-01-20T01:16:47.000000Z,2904603"}